Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topiramate versus haloperidol in children with chronic tic disorder
IRCT20230803059021N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of topiramate and haloperidol in chronic tic disorder (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoint: tic. Started Aug 2023; status: completed.
02
Drugs
topiramatehaloperidol
03
Conditions
chronic tic disorder
Beyond the preview
Go deeper on IRCT20230803059021N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230803059021N1.